₹809.00-26.55 (-3.18%)
04:01 PM, 14-Feb-2025₹818.15-7.60 (-0.92%)
03:47 PM, 14-Feb-2025BSE : 533573
NSE : APLLTD
Sector : Health care
ISIN Code : INE901L01018
Last Updated: 14-Feb-2025 | 04:01 PM IST
Market Cap (₹ Cr) | 15,901 |
Traded Value (₹ Cr) | 0.50 |
Volume (Shares) | 6,208 |
Face Value (₹) | 2 |
52-Week High (₹) | 1,296.15 |
52-Week High Date | 09-Oct-2024 |
52-Week Low (₹) | 802.80 |
52-Week Low Date | 14-Feb-2025 |
All Time High (₹) | 1,296.15 |
All Time High Date | 09-Oct-2024 |
All Time Low (₹) | 34.00 |
All Time Low Date | 02-Jan-2012 |
Intimation under Regulation 30 of SEBI LODR Regulations 2015 - Change in Senior Managerial Personnel
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 16,081 |
EPS - TTM (₹) [C] | 30.26 |
P/E Ratio (X) [C] | 27.04 |
Face Value (₹) | 2 |
Latest Dividend (%) | 550.00 |
Latest Dividend Date | 15-Jul-2024 |
Dividend Yield (%) | 1.34 |
Book Value Share (₹) [C] | 248.68 |
P/B Ratio (₹) [C] | 3.29 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Union Liquid Fund (G) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund (IDCW-M) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund (IDCW-Frt) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund (IDCW-W) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund (IDCW-D) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund - Direct (G) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund - Direct (IDCW-D) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund - Direct (IDCW-Frt) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund - Direct (IDCW-M) | 99.23 | 1,00,00,00,000 | 2.09 |
Union Liquid Fund - Direct (IDCW-W) | 99.23 | 1,00,00,00,000 | 2.09 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 802.45 830.95 |
Week Low/High (₹) | 802.45 918.00 |
Month Low/High (₹) | 802.45 1,067.00 |
Year Low/High (₹) | 802.45 1,304.00 |
All time Low/High (₹) | 34.00 1,304.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -7.89% | -7.73% | -2.47 | -2.68% |
1 Month | -18.93% | -18.95% | -0.73 | -1.06% |
3 Month | -20.55% | -20.41% | -2.12 | -2.56% |
6 Month | -22.91% | -22.97% | -4.00 | -5.03% |
1 Year | -16.56% | -16.58% | 5.73 | 4.99% |
3 Year | 11.06% | 11.06% | 34.63 | 36.14% |
Chairman and MD & CEO : Chirayu R Amin
Independent Director : Pranav N Parikh
Independent Director : K G Ramanathan
Independent Director : Paresh Saraiya
Director & CFO : Rajkumar Baheti
Independent Director : Milin Mehta
Managing Director : Pranav Amin
Managing Director : Shaunak Amin
Independent Director : Archana Hingorani
Company Secretary : Charandeep Singh Saluja
Registered Office: Alembic Road, ,Vadodara,Gujarat-390003 Ph: 91-0265-2280550
1. What's the Alembic Pharmaceuticals Ltd share price today?
Alembic Pharmaceuticals Ltd share price was Rs 809.00 at 04:01 PM IST on 14th Feb 2025. Alembic Pharmaceuticals Ltd share price was down by 3.18% from the previous closing price of Rs 835.55. Alembic Pharmaceuticals Ltd share price trend:
2. How can I quickly analyse the performance of the Alembic Pharmaceuticals Ltd stock?
The performance of the Alembic Pharmaceuticals Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Alembic Pharmaceuticals Ltd?
Alembic Pharmaceuticals Ltd has a market capitalisation of Rs 15,901 crore.
4. What is Alembic Pharmaceuticals Ltd's 52-week high/low share price?
The Alembic Pharmaceuticals Ltd’s 52-week high share price is Rs 1,296.15 and 52-week low share price is Rs 802.80.
5. Is the Alembic Pharmaceuticals Ltd profitable?
On a consolidated basis, Alembic Pharmaceuticals Ltd reported a profit of Rs 85.81 crore on a total income of Rs 1,421.55 crore for the quarter ended 2024. For the year ended Dec 2024, Alembic Pharmaceuticals Ltd had posted a profit of Rs 137.70 crore on a total income of Rs 1,702.60 crore.
6. Which are Alembic Pharmaceuticals Ltd’s peers in the Health care sector?
Alembic Pharmaceuticals Ltd’s top 5 peers in the Health care sector are Concord Biotech, Astrazeneca Phar, ERIS Lifescience, Alembic Pharma, Natco Pharma, Neuland Labs., Jubilant Pharmo.
7. Who owns how much in Alembic Pharmaceuticals Ltd?
Key changes to the Alembic Pharmaceuticals Ltd shareholding are as follows: